These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
310 related articles for article (PubMed ID: 11585303)
1. Somatostatin receptor-mediated imaging and therapy: basic science, current knowledge, limitations and future perspectives. Breeman WA; de Jong M; Kwekkeboom DJ; Valkema R; Bakker WH; Kooij PP; Visser TJ; Krenning EP Eur J Nucl Med; 2001 Sep; 28(9):1421-9. PubMed ID: 11585303 [TBL] [Abstract][Full Text] [Related]
2. Somatostatin-receptor-based imaging and therapy of gastroenteropancreatic neuroendocrine tumors. Kwekkeboom DJ; Kam BL; van Essen M; Teunissen JJ; van Eijck CH; Valkema R; de Jong M; de Herder WW; Krenning EP Endocr Relat Cancer; 2010 Mar; 17(1):R53-73. PubMed ID: 19995807 [TBL] [Abstract][Full Text] [Related]
3. Somatostatin receptor-targeted radionuclide therapy of tumors: preclinical and clinical findings. De Jong M; Valkema R; Jamar F; Kvols LK; Kwekkeboom DJ; Breeman WA; Bakker WH; Smith C; Pauwels S; Krenning EP Semin Nucl Med; 2002 Apr; 32(2):133-40. PubMed ID: 11965608 [TBL] [Abstract][Full Text] [Related]
4. Somatostatin receptor-targeted radionuclide therapy in patients with gastroenteropancreatic neuroendocrine tumors. Kwekkeboom DJ; de Herder WW; Krenning EP Endocrinol Metab Clin North Am; 2011 Mar; 40(1):173-85, ix. PubMed ID: 21349418 [TBL] [Abstract][Full Text] [Related]
5. DOTATOC: a powerful new tool for receptor-mediated radionuclide therapy. Otte A; Jermann E; Behe M; Goetze M; Bucher HC; Roser HW; Heppeler A; Mueller-Brand J; Maecke HR Eur J Nucl Med; 1997 Jul; 24(7):792-5. PubMed ID: 9211767 [TBL] [Abstract][Full Text] [Related]
6. Peptide receptor imaging and therapy. Kwekkeboom D; Krenning EP; de Jong M J Nucl Med; 2000 Oct; 41(10):1704-13. PubMed ID: 11038002 [TBL] [Abstract][Full Text] [Related]
7. Experience with indium-111 and yttrium-90-labeled somatostatin analogs. Virgolini I; Traub T; Novotny C; Leimer M; Füger B; Li SR; Patri P; Pangerl T; Angelberger P; Raderer M; Burggasser G; Andreae F; Kurtaran A; Dudczak R Curr Pharm Des; 2002; 8(20):1781-807. PubMed ID: 12171531 [TBL] [Abstract][Full Text] [Related]
8. Pre-therapeutic dosimetry with radiolabelled somatostatin analogues in patients with advanced neuroendocrine tumours. Forrer F; Mueller-Brand J; Maecke H Eur J Nucl Med Mol Imaging; 2005 Apr; 32(4):511-2; author reply 513. PubMed ID: 15688195 [No Abstract] [Full Text] [Related]
12. Comparison of 111In-DOTA-Tyr3-octreotide and 111In-DTPA-octreotide in the same patients: biodistribution, kinetics, organ and tumor uptake. Kwekkeboom DJ; Kooij PP; Bakker WH; Mäcke HR; Krenning EP J Nucl Med; 1999 May; 40(5):762-7. PubMed ID: 10319747 [TBL] [Abstract][Full Text] [Related]
13. Peptide receptor radionuclide therapy (PRRT) of neuroendocrine tumors with somatostatin analogues. Bodei L; Pepe G; Paganelli G Eur Rev Med Pharmacol Sci; 2010 Apr; 14(4):347-51. PubMed ID: 20496546 [TBL] [Abstract][Full Text] [Related]
14. Tumor imaging and therapy using radiolabeled somatostatin analogues. de Jong M; Breeman WA; Kwekkeboom DJ; Valkema R; Krenning EP Acc Chem Res; 2009 Jul; 42(7):873-80. PubMed ID: 19445476 [TBL] [Abstract][Full Text] [Related]
15. [Role of somatostatin analogs in the treatment of neuroendocrine tumours]. Cuccurullo V; Cascini GL; Rambaldi PF; Mansi L Minerva Endocrinol; 2001 Sep; 26(3):135-43. PubMed ID: 11753236 [TBL] [Abstract][Full Text] [Related]
16. [Scintigraphy of somatostatin receptors in the diagnosis and staging of neuroendocrine tumors of the digestive tract and pancreas]. Banzo J; Abós MD; Prats E; García F; Razola P Rev Esp Med Nucl; 2000 Jun; 19(3):225-41. PubMed ID: 11062088 [No Abstract] [Full Text] [Related]
17. Radiolabelled somatostatin analogue(s) for peptide receptor scintigraphy and radionuclide therapy. Krenning EP; de Jong M; Kooij PP; Breeman WA; Bakker WH; de Herder WW; van Eijck CH; Kwekkeboom DJ; Jamar F; Pauwels S; Valkema R Ann Oncol; 1999; 10 Suppl 2():S23-9. PubMed ID: 10399029 [TBL] [Abstract][Full Text] [Related]
18. MIBG and radiolabeled octreotide in neuroendocrine tumors. Hoefnagel CA Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):137-9. PubMed ID: 9002773 [TBL] [Abstract][Full Text] [Related]
19. Therapy of neuroendocrine tumors with radiolabeled somatostatin-analogues. De Jong M; Breeman WA; Bernard HF; Kooij PP; Slooter GD; Van Eijck CH; Kwekkeboom DJ; Valkema R; Mäcke HR; Krenning EP Q J Nucl Med; 1999 Dec; 43(4):356-66. PubMed ID: 10731786 [TBL] [Abstract][Full Text] [Related]